|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Amortization of deferred offering costs | |||
| Accretion of discounts and amortization of premiums | |||
| Net realized (gain) loss on investments | |||
| Net realized (gain) loss on forward currency contracts | |||
| Net realized (gain) loss on foreign currency transactions | |||
| Net change in unrealized (appreciation) depreciation on investments | |||
| Net change in unrealized (appreciation) depreciation on forward currency contracts | |||
| Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies | |||
| Proceeds from (fundings of) revolving loans, net | |||
| Fundings of investments | |||
| Proceeds from principal payments and sales of portfolio investments | |||
| Funding of settlements of forward currency contracts | |||
| Payment-in-kind interest capitalized | |||
| Non-cash dividends capitalized | |||
| Proceeds from non-cash dividends | |||
| Changes in operating assets and liabilities: | |||
| Cash collateral for forward currency contracts | |||
| Interest receivable | |||
| Receivable for investments | |||
| Other assets | |||
| Payable for investments purchased | |||
| Management and income incentive fees payable | |||
| Accrued trustee fees | |||
| Accounts payable and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from financing activities | |||
| Borrowings on debt | |||
| Repayments of debt | |||
| Deferred offering costs | |||
| Proceeds from issuance of common shares | |||
| Distributions paid | |||
| Net cash provided by (used in) financing activities | |||
| Net change in cash and cash equivalents and foreign currencies | |||
| Effect of foreign currency exchange rates | |||
| Cash and cash equivalents and foreign currencies, beginning of period | |||
| Cash and cash equivalents and foreign currencies, end of period | |||
| Supplemental disclosure of cash flow information: | |||
| Distributions declared for the period | |||
| Supplemental disclosure of non-cash operating and financing activity: | |||
| Stock issued in connection with dividend reinvestment plan | |||
| Change in distributions payable | |||
| Cash and cash equivalents | |||
| Foreign currencies (cost of $351,577 and $4,455, respectively) |
Loading...